These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17952760)

  • 1. Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats.
    Kumru S; Yildiz AA; Yilmaz B; Sandal S; Gurates B
    Gynecol Endocrinol; 2007 Oct; 23(10):556-61. PubMed ID: 17952760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of letrozole on hippocampal and cortical catecholaminergic neurotransmitter levels, neural cell adhesion molecule expression and spatial learning and memory in female rats.
    Aydin M; Yilmaz B; Alcin E; Nedzvetsky VS; Sahin Z; Tuzcu M
    Neuroscience; 2008 Jan; 151(1):186-94. PubMed ID: 18061360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S; Kajantie E; Dunkel L
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats.
    Mohamed I; Yeh JK
    J Endocrinol; 2009 Aug; 202(2):317-25. PubMed ID: 19420010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tocolytic agent: effects of letrozole on gestational length and parturition time.
    Kafali H; Iriadam M
    Am J Perinatol; 2007 May; 24(5):323-6. PubMed ID: 17516308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.
    Brufsky A; Bundred N; Coleman R; Lambert-Falls R; Mena R; Hadji P; Jin L; Schenk N; Ericson S; Perez EA;
    Oncologist; 2008 May; 13(5):503-14. PubMed ID: 18515735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Gasser JA; Green JR; Shen V; Ingold P; Rebmann A; Bhatnagar AS; Evans DB
    Bone; 2006 Oct; 39(4):787-95. PubMed ID: 16844441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase activity after a short-course of letrozole administration in adult men at sea level and at high altitude (with or without excessive erythrocytosis).
    Gonzales GF; Tapia V; Gasco M; Gonzales-Castañeda C
    Horm Metab Res; 2012 Feb; 44(2):140-5. PubMed ID: 22274717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the aromatase inhibitor letrozole on in utero development in rats.
    Tiboni GM; Marotta F; Rossi C; Giampietro F
    Hum Reprod; 2008 Aug; 23(8):1719-23. PubMed ID: 18487213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats.
    Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
    Clin Cancer Res; 2004 Sep; 10(17):5717-23. PubMed ID: 15355898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of metformin and letrozole on endometrium and ovary in a rat model.
    Oner G; Ozcelik B; Ozgun MT; Ozturk F
    Gynecol Endocrinol; 2011 Dec; 27(12):1084-6. PubMed ID: 21770833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model.
    Oner G; Ozcelik B; Ozgun MT; Serin IS; Ozturk F; Basbug M
    Hum Reprod; 2010 Apr; 25(4):932-7. PubMed ID: 20133323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
    de Boer H; Verschoor L; Ruinemans-Koerts J; Jansen M
    Diabetes Obes Metab; 2005 May; 7(3):211-5. PubMed ID: 15811136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of testosterone and oestrogen on gonadectomised and intact male rat anterior pituitary mitotic and apoptotic activity.
    Nolan LA; Levy A
    J Endocrinol; 2006 Mar; 188(3):387-96. PubMed ID: 16522719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.
    Bundred NJ; Campbell ID; Davidson N; DeBoer RH; Eidtmann H; Monnier A; Neven P; von Minckwitz G; Miller JC; Schenk NL; Coleman RE
    Cancer; 2008 Mar; 112(5):1001-10. PubMed ID: 18205185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of letrozole on urinary bladder function in the female rabbit.
    Lin WY; Rehfuss A; Whitbeck C; Juan YS; Chichester P; Mannikarottu A; Levin RM
    BJU Int; 2007 Dec; 100(6):1391-5. PubMed ID: 17850373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on superovulation in Asian women with normal ovulatory cycles.
    Topipat C; Choktanasiri W; Jultanmas R; Weerakiet S; Wongkularb A; Rojanasakul A
    Gynecol Endocrinol; 2008 Mar; 24(3):145-50. PubMed ID: 18335329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
    Gargano V; Massaro M; Morra I; Formisano C; Di Carlo C; Nappi C
    Contraception; 2008 Jul; 78(1):10-5. PubMed ID: 18555812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
    Hero M; Mäkitie O; Kröger H; Nousiainen E; Toiviainen-Salo S; Dunkel L
    Horm Res; 2009; 71(5):290-7. PubMed ID: 19339794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of delayed male puberty: efficacy of aromatase inhibition.
    Dunkel L; Wickman S
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1541-6. PubMed ID: 11837512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.